Developmental control of integrin expression regulates Th2 effector homing

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 4656-4667

  Lee, Seung Hyo ^a,c   Prince, Joseph E ^a   Rais, Muhammad ^a   Kheradmand, Farrah ^a   Ballantyne, Christie M ^a   Weitz Schmidt, Gabriele ^b   Smith, C Wayne ^a   Corry, David B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Korea National Institute of Health   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADDRESSIN; ALLERGEN; BETA1 INTEGRIN; GAMMA INTERFERON; INTEGRIN; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; IMMUNE RESPONSE; IN VITRO STUDY; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; WILD TYPE; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; LUNG DISEASE; METABOLISM; MOUSE MUTANT;

ALLERGENS; ANIMALS; ANTIGENS, CD11A; ANTIGENS, CD29; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; GENE EXPRESSION REGULATION; HYPERSENSITIVITY; INTEGRINS; LEISHMANIA MAJOR; LUNG DISEASES; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, KNOCKOUT; TH1 CELLS; TH2 CELLS;

EID: 44449110166     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.4656     Document Type: Article

References (55)

1. Aplin, A. E., A. Howe, S. K. Alahari, and R. L. Juliano. 1998. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev. 50: 197-263.
2. Harris, E. S., T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 2000. The leukocyte integrins. J. Biol. Chem. 275: 23409-23412.
3. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346: 425-434.
4. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
5. Pribila, J. T., A. C. Quale, K. L. Mueller, and Y. Shimizu. 2004. Integrins and T cell-mediated immunity. Annu. Rev. Immunol. 22: 157-180.
6. 2, CD11a/CD18) heterodimer formation and ligand binding. FEBS Lett. 440: 414-418.
7. Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood 84: 2068 -2101.
8. Wagner, C., G. M. Hansch, S. Stegmaier, B. Denefleh, F. Hug, and M. Schoels. 2001. The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function. Eur. J. Immunol. 31: 1173-1180.
9. von Andrian, U. H., and C. R. Mackay. 2000. T-cell function and migration: two sides of the same coin. N. Engl. J. Med. 343: 1020 -1034.
10. Dustin, M. L., and T. A. Springer. 1989. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341: 619 -624.
11. Campbell, J. J., J. Hedrick, A. Zlotnik, M. A. Siani, D. A. Thompson, and E. C. Butcher. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279: 381-384.
12. Hogg, N., M. Laschinger, K. Giles, and A. McDowall. 2003. T-cell integrins: more than just sticking points. J. Cell Sci. 116: 4695-4705.
13. Grakoui, A., S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-227.
14. Van Seventer, G. A., Y. Shimizu, K. J. Horgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor- mediated activation of resting T cells. J. Immunol. 144: 4579 -4586.
15. Lee, S. H., J. E. Prince, M. Rais, F. Kheradmand, F. Shardonofsky, H. Lu, A. L. Beaudet, C. W. Smith, L. Soong, and D. B. Corry. 2003. Differential requirement for CD18 in T-helper effector homing. Nat. Med. 9: 1281-1286.
16. Ding, Z. M., J. E. Babensee, S. I. Simon, H. Lu, J. L. Perrard, D. C. Bullard, X. Y. Dai, S. K. Bromley, M. L. Dustin, M. L. Entman, et al. 1999. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J. Immunol. 163: 5029 -5038.
17. Sligh, J. E., Jr., C. M. Ballantyne, S. S. Rich, H. K. Hawkins, C. W. Smith, A. Bradley, and A. L. Beaudet. 1993. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 90: 8529 -8533.
18. low thymocytes in vivo. Science 250: 1720 -1723.
19. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183: 109 -117. 20. Corry, D. B., G. Grunig, H. Hadeiba, V. P. Kurup, M. L. Warnock, D. Sheppard, D. M. Rennick, and R. M. Locksley. 1998. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol. Med. 4: 344-355.
20. Corry, D. B., K. Rishi, J. Kanellis, A. Kiss, L. Z. Song Lz, J. Xu, L. Feng, Z. Werb, and F. Kheradmand. 2002. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat. Immunol. 3: 347-353.
21. Corry, D. B., S. L. Reiner, P. S. Linsley, and R. M. Locksley. 1994. Differential effects of blockade of CD28 -B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153: 4142-4148.
22. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, Jr., N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40- CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4: 263-273.
23. Lee, S. H., A. Kiss, J. Xu, Y. Qian, L. Bashoura, F. Kheradmand, and D. B. Corry. 2004. Airway glycoprotein secretion parallels production and predicts airway obstruction in pulmonary allergy. J. Allergy Clin. Immunol. 113: 72-78.
24. Nishimura, T., H. Yagi, N. Sato, S. Ohta, and Y. Hashimoto. 1987. The role of lymphokine-activated cell-associated antigen: III. Inhibition of T-cell activation by monoclonal killer-blocking antibody. Cell. Immunol. 107: 32-39.
25. Weitz-Schmidt, G., K. Welzenbach, V. Brinkmann, T. Kamata, J. Kallen, C. Bruns, S. Cottens, Y. Takada, and U. Hommel. 2001. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7: 687-692.
26. Shappell, S. B., C. Toman, D. C. Anderson, A. A. Taylor, M. L. Entman, and C. W. Smith. 1990. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J. Immunol. 144: 2702-2711.
27. Mickelson, J. K., M. N. Ali, N. S. Kleiman, N. M. Lakkis, T. W. Chow, B. J. Hughes, and C. W. Smith. 1999. Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty. J. Am. Coll. Cardiol. 33: 97-106.
28. Abbassi, O., T. K. Kishimoto, L. V. McIntire, D. C. Anderson, and C. W. Smith. 1993. E-selectin supports neutrophil rolling in vitro under conditions of flow. J. Clin. Invest. 92: 2719 -2730.
29. Mariscalco, M. M., M. H. Tcharmtchi, and C. W. Smith. 1998. P-Selectin support of neonatal neutrophil adherence under flow: contribution of L-selectin, LFA-1, and ligand(s) for P-selectin. Blood 91: 4776 -4785.
30. Corry, D. B. 2002. Emerging immune targets for the therapy of allergic asthma. Nat. Rev. Drug Discov. 1: 55-64.
31. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley.
32. 1989. Reciprocal expression of interferon y or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169: 59 -72.
33. Locksley, R. M., F. P. Heinzel, M. D. Sadick, B. J. Holaday, and K. D. Gardner, Jr. 1987. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann. Inst. Pasteur Immunol. 138: 744-749.
34. + T cell-intrinsic mechanism. J. Exp. Med. 188: 2289 -2299.
35. + cytotoxic T cell activation and memory in virus infection. J. Immunol. 149: 1326 -1333.
36. + human T cells: activation requirements and association with HLA-DR alleles. J. Immunol. 157: 4771-4780.
37. + T cells in vivo. J. Immunol. 154: 5684-5693.
38. Wu, H., J. R. Rodgers, X. Y. Perrard, J. L. Perrard, J. E. Prince, Y. Abe, B. K. Davis, G. Dietsch, C. W. Smith, and C. M. Ballantyne. 2004. Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes. J. Immunol. 173: 297-306.
39. Kanwar, S., C. W. Smith, F. R. Shardonofsky, and A. R. Burns. 2001. The role of Mac-1 (CD11b/CD18) in antigen-induced airway eosinophilia in mice. Am. J. Respir. Cell Mol. Biol. 25: 170 -177.
40. Miyamoto, M., M. Emoto, Y. Emoto, V. Brinkmann, I. Yoshizawa, P. Seiler, P. Aichele, E. Kita, and S. H. Kaufmann. 2003. Neutrophilia in LFA-1-deficient mice confers resistance to listeriosis: possible contribution of granulocyte-colo- ny-stimulating factor and IL-17. J. Immunol. 170: 5228 -5234.
41. Emoto, M., M. Miyamoto, Y. Emoto, I. Yoshizawa, V. Brinkmann, N. van Rooijen, and S. H. Kaufmann. 2003. Highly biased type 1 immune responses in mice deficient in LFA-1 in Listeria monocytogenes infection are caused by elevated IL-12 production by granulocytes. J. Immunol. 171: 3970 -3976.
42. Wu, H., J. E. Prince, C. F. Brayton, C. Shah, D. Zeve, S. H. Gregory, C. W. Smith, and C. M. Ballantyne. 2003. Host resistance of CD18 knockout mice against systemic infection with Listeria monocytogenes. Infect. Immun. 71: 5986 -5993.
43. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272: 60 -66.
44. + I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112: 99-111.
45. Oxvig, C., C. Lu, and T. A. Springer. 1999. Conformational changes in tertiary structure near the ligand binding site of an integrin I domain. Proc. Natl. Acad. Sci. USA 96: 2215-2220.
46. + T cells unresponsive to IL-12. J. Infect. Dis. 183: 953-959.
47. Pirmez, C., M. Yamamura, K. Uyemura, M. Paes-Oliveira, F. Conceicao-Silva, and R. L. Modlin. 1993. Cytokine patterns in the pathogenesis of human leish-maniasis. J. Clin. Invest. 91: 1390 -1395.
48. Yamamura, M., K. Uyemura, R. J. Deans, K. Weinberg, T. H. Rea, B. R. Bloom, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254: 277-279.
49. Morosini, M., F. Meloni, M. Uccelli, A. Marone Bianco, N. Solari, and A. M. Fietta. 2005. Ex vivo evaluation of PPD-specific IFN-γ or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis. Int. J. Tuberc. Lung Dis. 9: 753-759.
50. Ordway, D. J., Costa, M. Martins, H. Silveira, Amaral, M. J. Arroz, F. A. Ventura, and H. M. Dockrell. 2004. Increased interleukin-4 production by CD8 and γδ T cells in health-care workers is associated with the subsequent development of active tuberculosis. J. Infect. Dis. 190: 756 -766.
51. Fletcher, H. A., P. Owiafe, D. Jeffries, P. Hill, G. A. Rook, A. Zumla, T. M. Doherty, and R. H. Brookes. 2004. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-462 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology 112: 669 -673.
52. Lienhardt, C., A. Azzurri, A. Amedei, K. Fielding, J. Sillah, O. Y. Sow, B. Bah, M. Benagiano, A. Diallo, R. Manetti, et al. 2002. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur. J. Immunol. 32: 1605-1613.
53. Mendez-Tovar, L. J., R. Mondragon-Gonzalez, F. Vega-Lopez, H. M. Dockrell, R. Hay, R. Lopez-Martinez, P. Manzano-Gayosso, F. Hernandez-Hernandez, C. Padilla-Desgarennes, and A. Bonifaz. 2004. Cytokine production and lymphocyte proliferation in patients with Nocardia brasiliensis actinomycetoma. My- copathologia 158: 407-414.
54. Holgate, S. T. 1999. The epidemic of allergy and asthma. Nature 402: B2-B4.
55. Kleinschmidt-DeMasters, B. K., and K. L. Tyler. 2005. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon |3-1a for multiple sclerosis. N. Engl. J. Med. 353: 369-374.